Provider

The funding will advance research for eye treatment devices and assist in the development of future eye care products for myopia control.

A new study of 27,000 virtual physiotherapy patients has concluded that digital physiotherapy must become a significant part of the treatment mix post COVID-19.

A clinical trial at the University of Antwerp found that patients perceived an improvement in cognitive function after playing using MyCognition app. 

CereCore Vice President Peyman Zand discusses why prospective analytics must include business continuity scenarios that can be upended 180 degrees.

The company is also looking to fast-track its opioid use disorder therapy, thanks to relaxed FDA guidelines. 

Cam Deemer, president of DrFirst, says the pandemic has forced the adoption of telehealth and other technologies that already existed.

The new project will use wearable technology to enable vulnerable patients at home to be remotely monitored by hospital clinicians.

The masks use Swiss company HeiQ's Viroblock "intelligent textile technology", which was designed to eliminate a range of bacteria and viruses. 

The Access Initiative for Quitting Tobacco and will first be piloted in Jordan. 

This week's top stories include primary care doctors saying they're not ready for the next COVID-19 surge, Philips building out the VA's telehealth infrastructure, and Novartis and Propeller Health co-packaging a new asthma treatment.